01 July 2024
The director of the Gamaleya Research Institute of Epidemiology and Microbiology, Alexander Gintsburg, has announced the upcoming launch of clinical studies for a cancer vaccine involving cancer patients by mid-2025. This vaccine is currently undergoing preclinical testing on mice.
Alexander Ginzburg noted that the vaccine is now being tested as part of preclinical studies on mice, and technology is being developed to not just extend the life of animals with melanoma by two to three times, but to create drugs that would guarantee the destruction of both the tumor and metastases.
PrintDespite high concordance and initial translation, why do animal studies rarely lead to approvals?
03 July 2024
Putin approved a list of instructions on healthcare development issues
03 July 2024
New draft guidance promotes diversity in clinical trials
02 July 2024
Innovative small molecule shows promise in obesity
02 July 2024